MoneyWorks4Me

Gufic Biosciences informs about demise of director

02 Apr 2024 Evaluate
Gufic Biosciences has informed about the sad demise of Shrirang Vaidya (DIN: 03618800), Independent Director of the Company on April 1, 2024. His sudden and unexpected passing away will be an irreparable loss to the Company and all the directors and employees of the Company convey deep sympathy, sorrow and condolences to his family. Further, informed that he would be ceased to be the Chairman of Audit Committee and Nomination and Remuneration Committee and Member of Risk Management Committee of the Company. The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular No.   SEBI/HO/CFD/CFD?PoD?1/P/CIR/2023/123 dated July 13, 2023 is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..